Evidence map›Paper›PMID 35788238›Full record

ArticleGenome biology2022

GoPeaks: histone modification peak calling for CUT&Tag.

William M Yashar, Garth Kong, Jake VanCampen, Brittany M Curtiss, Daniel J Coleman, Lucia Carbone, Galip Gürkan Yardimci, Julia E Maxson, Theodore P Braun

Abstract read
In one paragraph

Article in Genome biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Differential Wnt/β-catenin signaling via TCF7L2/LEF1 binding specificity shapes cellular and tumor phenotypes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Benchmarking peak calling methods for CUT&RUN.Bioinformatics (Oxford, England) · 2025
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

William M Yashar *Knight Cancer Institute, Oregon Health & Science University, Portland, USA.
Garth Kong *Knight Cancer Institute, Oregon Health & Science University, Portland, USA.
Jake VanCampen *Knight Cancer Institute, Oregon Health & Science University, Portland, USA.
Brittany M Curtiss *Knight Cancer Institute, Oregon Health & Science University, Portland, USA.
Daniel J ColemanKnight Cancer Institute, Oregon Health & Science University, Portland, USA.
Lucia CarboneKnight Cardiovascular Institute, Oregon Health & Science University, Portland, USA.
Galip Gürkan YardimciKnight Cancer Institute, Oregon Health & Science University, Portland, USA.
Julia E MaxsonKnight Cancer Institute, Oregon Health & Science University, Portland, USA.
Theodore P BraunKnight Cancer Institute, Oregon Health & Science University, Portland, USA. braunt@ohsu.edu.ORCID 0000-0002-6248-2143

Funding

Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AMLU54CA224019 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Tothu Q Vu · 2017 to 2026
$13.9M
Role of ASXL1 in normal and abnormal granulopoiesis.R01HL157147 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI MAXSON, JULIA E · 2021 to 2025
$2.4M
Medical Scientist Training Program of Oregon Health & Science UniversityT32GM109835 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI JACOBY, DAVID B · 2016 to 2020
$1.1M
Epigenetics of Mutation-Order in Acute Myeloid LeukemiaK08CA245224 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI BRAUN, THEODORE PAUL · 2020 to 2024
$812k
NCI NIH HHS K08 CA245224NCI NIH HHS U54 CA224019NHLBI NIH HHS R01 HL157147NIGMS NIH HHS T32 GM109835
6 · The paper itself

Abstract

Genome-wide mapping of histone modifications is critical to understanding transcriptional regulation. CUT&Tag is a new method for profiling histone modifications, offering improved sensitivity and decreased cost compared with ChIP-seq. Here, we present GoPeaks, a peak calling method specifically designed for histone modification CUT&Tag data. We compare the performance of GoPeaks against commonly used peak calling algorithms to detect histone modifications that display a range of peak profiles and are frequently used in epigenetic studies. We find that GoPeaks robustly detects genome-wide histone modifications and, notably, identifies a substantial number of H3K27ac peaks with improved sensitivity compared to other standard algorithms.

Indexed as

Histone CodeProtein Processing, Post-TranslationalChromatin ImmunoprecipitationGenomeSequence Analysis, DNAATAC-seqChIP-seqCUT&RUNCUT&TagEpigeneticsGoPeaksHistone modificationsMACS2Peak callingSEACR

Identifiers

PMID35788238
PMCPMC9252088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.